{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:24:07Z","timestamp":1777929847537,"version":"3.51.4"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T00:00:00Z","timestamp":1240272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T00:00:00Z","timestamp":1240272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Onkologie"],"abstract":"<jats:p>48 Patientinnen mit diffus skelettmetastasiertem Mammakarzinom wurden einer Behandlung mit Salm-Calc\u00eftonin in Verbindung mit einer Polychemo- oder Hormontherapie unterzogen und einer vergleichbaren Kontrollgruppe von 73 Patientinnen gegen\u00fcbergestellt. Calcitonin zeigte in einem Drittel der F\u00e4lle einen ausgepr\u00e4gten schmerzpalliativen Effekt, der sich unabh\u00e4ngig von der Wirksamkeit der spezifischen Therapie einstellte. Obwohl nur subjektive Kriterien zur Beurteilung der Schmerzpalliation herangezogen wurden und keine Behandlungsgruppe untersucht wurde, die Calcitonin allein erhalten hatte, sollten die Ergebnisse der Studie im Vergleich mit den vorliegenden Berichten \u00fcber Calcitonin und Skelettmetastasen gesehen werden.<\/jats:p>","DOI":"10.1159\/000215425","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T10:40:22Z","timestamp":1240396822000},"page":"137-140","source":"Crossref","is-referenced-by-count":0,"title":["Calcitonin beim skelettmetastasierten Mammakarzinom"],"prefix":"10.1159","author":[{"given":"F.","family":"Beaufort","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"G\u00f6lles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2009,4,21]]},"container-title":["Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/215425","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000215425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:55:27Z","timestamp":1777679727000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000215425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,21]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000215425","archive":["Portico"],"relation":{},"ISSN":["0378-584X","1423-0240"],"issn-type":[{"value":"0378-584X","type":"print"},{"value":"1423-0240","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,21]]}}}